Miravant Medical Technologies Inc.
MRVT · OTC
12/31/2004 | 12/31/2003 | 12/31/2002 | 12/31/2001 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.03 | 0.07 | 0.10 | 0.29 |
| FCF Yield | -34.60% | -35.21% | -45.76% | -8.67% |
| EV / EBITDA | -3.00 | -1.75 | -2.20 | -14.71 |
| Quality | ||||
| ROIC | 180.96% | 3,588.71% | 815.83% | 116.16% |
| Gross Margin | 0.00% | 0.00% | 4.01% | 80.06% |
| Cash Conversion Ratio | 0.73 | 1.45 | 0.54 | 0.93 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -52.28% | -31.51% |
| Free Cash Flow Growth | -3.54% | -29.92% | 44.83% | -13.92% |
| Safety | ||||
| Net Debt / EBITDA | -0.36 | -0.29 | -0.82 | -1.81 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 2.36 |
| Cash Conversion Cycle | 0.00 | 0.00 | -1,037.09 | -444.25 |